APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Medications for Alcohol Use Disorder (AUD)

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Medications for Alcohol Use Disorder (AUD) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174011310327 December 2025192 pages

Choose your research edition.

Industry ResearchMedications for Alcohol Use Disorder (AUD) Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Medications for Alcohol Use Disorder (AUD) Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Medications for Alcohol Use Disorder (AUD) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medications for Alcohol Use Disorder (AUD) Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Medications for Alcohol Use Disorder (AUD) Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Medications for Alcohol Use Disorder (AUD) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Medications for Alcohol Use Disorder (AUD) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Medications for Alcohol Use Disorder (AUD) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Medications for Alcohol Use Disorder (AUD) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Medications for Alcohol Use Disorder (AUD) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Medications for Alcohol Use Disorder (AUD) include Teva, Sun Pharmaceutical Industries, Merck KGaA, Mylan, Beijing Wellso Pharmaceutical Co, Zydus Pharmaceuticals, Taj Pharmaceuticals, TAGI Pharma Inc. and Rusan Pharma Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Medications for Alcohol Use Disorder (AUD) market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Medications for Alcohol Use Disorder (AUD) and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Medications for Alcohol Use Disorder (AUD) revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Medications for Alcohol Use Disorder (AUD) market size, projected growth trends, production technologies, key applications, and end-use industries.

Medications for Alcohol Use Disorder (AUD) Segment by Company

Teva

Sun Pharmaceutical Industries

Merck KGaA

Mylan

Beijing Wellso Pharmaceutical Co

Zydus Pharmaceuticals

Taj Pharmaceuticals

TAGI Pharma Inc.

Rusan Pharma Ltd

Lundbeck

Glenmark Pharmaceuticals

Alvogen

Alkermes

Medications for Alcohol Use Disorder (AUD) Segment by Type

Acamprosate

Naltrexone

Disulfiram

Other

Medications for Alcohol Use Disorder (AUD) Segment by Application

Hospital

Rehabilitation Institutions

Others

Medications for Alcohol Use Disorder (AUD) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medications for Alcohol Use Disorder (AUD) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medications for Alcohol Use Disorder (AUD) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medications for Alcohol Use Disorder (AUD).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Medications for Alcohol Use Disorder (AUD) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medications for Alcohol Use Disorder (AUD) industry.

Chapter 3: Detailed analysis of Medications for Alcohol Use Disorder (AUD) companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Medications for Alcohol Use Disorder (AUD)revenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Acamprosate Table 3. Key Players of Naltrexone Table 4. Key Players of Disulfiram Table 3. Key Players of Other Table 4. Global Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Table 6. Key Players of Rehabilitation Institutions Table 7. Key Players of Others Table 8. Global Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Medications for Alcohol Use Disorder (AUD) Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Medications for Alcohol Use Disorder (AUD) Market Share by Region (2021-2026) Table 11. Global Medications for Alcohol Use Disorder (AUD) Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Medications for Alcohol Use Disorder (AUD) Market Share by Region (2027-2032) Table 13. Medications for Alcohol Use Disorder (AUD) Industry Trends Table 14. Medications for Alcohol Use Disorder (AUD) Industry Drivers Table 15. Medications for Alcohol Use Disorder (AUD) Industry Opportunities and Challenges Table 16. Medications for Alcohol Use Disorder (AUD) Industry Restraints Table 17. Global Medications for Alcohol Use Disorder (AUD) Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Medications for Alcohol Use Disorder (AUD) Revenue Market Share by Company (2021-2026) Table 19. Global Medications for Alcohol Use Disorder (AUD) Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Medications for Alcohol Use Disorder (AUD) Key Company Head Office and Area Served Table 21. Global Medications for Alcohol Use Disorder (AUD) Company, Product Type & Application Table 22. Global Medications for Alcohol Use Disorder (AUD) Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Medications for Alcohol Use Disorder (AUD) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Medications for Alcohol Use Disorder (AUD) Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Medications for Alcohol Use Disorder (AUD) Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Medications for Alcohol Use Disorder (AUD) Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Medications for Alcohol Use Disorder (AUD) Revenue Market Share by Type (2021-2026) Table 29. Global Medications for Alcohol Use Disorder (AUD) Revenue Market Share by Type (2027-2032) Table 30. Global Medications for Alcohol Use Disorder (AUD) Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Medications for Alcohol Use Disorder (AUD) Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Medications for Alcohol Use Disorder (AUD) Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Medications for Alcohol Use Disorder (AUD) Revenue Market Share by Application (2021-2026) Table 34. Global Medications for Alcohol Use Disorder (AUD) Revenue Market Share by Application (2027-2032) Table 35. Teva Company Information Table 36. Teva Business Overview Table 37. Teva Medications for Alcohol Use Disorder (AUD) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Teva Medications for Alcohol Use Disorder (AUD) Product Portfolio Table 39. Teva Recent Development Table 40. Sun Pharmaceutical Industries Company Information Table 41. Sun Pharmaceutical Industries Business Overview Table 42. Sun Pharmaceutical Industries Medications for Alcohol Use Disorder (AUD) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Sun Pharmaceutical Industries Medications for Alcohol Use Disorder (AUD) Product Portfolio Table 44. Sun Pharmaceutical Industries Recent Development Table 45. Merck KGaA Company Information Table 46. Merck KGaA Business Overview Table 47. Merck KGaA Medications for Alcohol Use Disorder (AUD) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Merck KGaA Medications for Alcohol Use Disorder (AUD) Product Portfolio Table 49. Merck KGaA Recent Development Table 50. Mylan Company Information Table 51. Mylan Business Overview Table 52. Mylan Medications for Alcohol Use Disorder (AUD) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Mylan Medications for Alcohol Use Disorder (AUD) Product Portfolio Table 54. Mylan Recent Development Table 55. Beijing Wellso Pharmaceutical Co Company Information Table 56. Beijing Wellso Pharmaceutical Co Business Overview Table 57. Beijing Wellso Pharmaceutical Co Medications for Alcohol Use Disorder (AUD) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Beijing Wellso Pharmaceutical Co Medications for Alcohol Use Disorder (AUD) Product Portfolio Table 59. Beijing Wellso Pharmaceutical Co Recent Development Table 60. Zydus Pharmaceuticals Company Information Table 61. Zydus Pharmaceuticals Business Overview Table 62. Zydus Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Zydus Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Product Portfolio Table 64. Zydus Pharmaceuticals Recent Development Table 65. Taj Pharmaceuticals Company Information Table 66. Taj Pharmaceuticals Business Overview Table 67. Taj Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Taj Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Product Portfolio Table 69. Taj Pharmaceuticals Recent Development Table 70. TAGI Pharma Inc. Company Information Table 71. TAGI Pharma Inc. Business Overview Table 72. TAGI Pharma Inc. Medications for Alcohol Use Disorder (AUD) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. TAGI Pharma Inc. Medications for Alcohol Use Disorder (AUD) Product Portfolio Table 74. TAGI Pharma Inc. Recent Development Table 75. Rusan Pharma Ltd Company Information Table 76. Rusan Pharma Ltd Business Overview Table 77. Rusan Pharma Ltd Medications for Alcohol Use Disorder (AUD) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Rusan Pharma Ltd Medications for Alcohol Use Disorder (AUD) Product Portfolio Table 79. Rusan Pharma Ltd Recent Development Table 80. Lundbeck Company Information Table 81. Lundbeck Business Overview Table 82. Lundbeck Medications for Alcohol Use Disorder (AUD) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Lundbeck Medications for Alcohol Use Disorder (AUD) Product Portfolio Table 84. Lundbeck Recent Development Table 85. Glenmark Pharmaceuticals Company Information Table 86. Glenmark Pharmaceuticals Business Overview Table 87. Glenmark Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Glenmark Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Product Portfolio Table 89. Glenmark Pharmaceuticals Recent Development Table 90. Alvogen Company Information Table 91. Alvogen Business Overview Table 92. Alvogen Medications for Alcohol Use Disorder (AUD) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Alvogen Medications for Alcohol Use Disorder (AUD) Product Portfolio Table 94. Alvogen Recent Development Table 95. Alkermes Company Information Table 96. Alkermes Business Overview Table 97. Alkermes Medications for Alcohol Use Disorder (AUD) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. Alkermes Medications for Alcohol Use Disorder (AUD) Product Portfolio Table 99. Alkermes Recent Development Table 100. North America Medications for Alcohol Use Disorder (AUD) Market Size by Type (2021-2026) & (US$ Million) Table 101. North America Medications for Alcohol Use Disorder (AUD) Market Size by Type (2027-2032) & (US$ Million) Table 102. North America Medications for Alcohol Use Disorder (AUD) Market Size by Application (2021-2026) & (US$ Million) Table 103. North America Medications for Alcohol Use Disorder (AUD) Market Size by Application (2027-2032) & (US$ Million) Table 104. North America Medications for Alcohol Use Disorder (AUD) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. North America Medications for Alcohol Use Disorder (AUD) Market Size by Country (2021-2026) Table 106. North America Medications for Alcohol Use Disorder (AUD) Market Size by Country (2027-2032) Table 107. Europe Medications for Alcohol Use Disorder (AUD) Market Size by Type (2021-2026) & (US$ Million) Table 108. Europe Medications for Alcohol Use Disorder (AUD) Market Size by Type (2027-2032) & (US$ Million) Table 109. Europe Medications for Alcohol Use Disorder (AUD) Market Size by Application (2021-2026) & (US$ Million) Table 110. Europe Medications for Alcohol Use Disorder (AUD) Market Size by Application (2027-2032) & (US$ Million) Table 111. Europe Medications for Alcohol Use Disorder (AUD) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. Europe Medications for Alcohol Use Disorder (AUD) Market Size by Country (2021-2026) Table 113. Europe Medications for Alcohol Use Disorder (AUD) Market Size by Country (2027-2032) Table 114. China Medications for Alcohol Use Disorder (AUD) Market Size by Type (2021-2026) & (US$ Million) Table 115. China Medications for Alcohol Use Disorder (AUD) Market Size by Type (2027-2032) & (US$ Million) Table 116. China Medications for Alcohol Use Disorder (AUD) Market Size by Application (2021-2026) & (US$ Million) Table 117. China Medications for Alcohol Use Disorder (AUD) Market Size by Application (2027-2032) & (US$ Million) Table 118. Asia Medications for Alcohol Use Disorder (AUD) Market Size by Type (2021-2026) & (US$ Million) Table 119. Asia Medications for Alcohol Use Disorder (AUD) Market Size by Type (2027-2032) & (US$ Million) Table 120. Asia Medications for Alcohol Use Disorder (AUD) Market Size by Application (2021-2026) & (US$ Million) Table 121. Asia Medications for Alcohol Use Disorder (AUD) Market Size by Application (2027-2032) & (US$ Million) Table 122. Asia Medications for Alcohol Use Disorder (AUD) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Asia Medications for Alcohol Use Disorder (AUD) Market Size by Country (2021-2026) Table 124. Asia Medications for Alcohol Use Disorder (AUD) Market Size by Country (2027-2032) Table 125. South America, Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size by Type (2021-2026) & (US$ Million) Table 126. South America, Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size by Type (2027-2032) & (US$ Million) Table 127. South America, Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size by Application (2021-2026) & (US$ Million) Table 128. South America, Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size by Application (2027-2032) & (US$ Million) Table 129. South America, Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. South America, Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size by Country (2021-2026) Table 131. South America, Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size by Country (2027-2032) Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. Medications for Alcohol Use Disorder (AUD) Product Image Figure 2. Global Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Medications for Alcohol Use Disorder (AUD) Market Share by Type: 2025 VS 2032 Figure 4. Acamprosate Image Figure 5. Naltrexone Image Figure 6. Disulfiram Image Figure 7. Other Image Figure 8. Global Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Medications for Alcohol Use Disorder (AUD) Market Share by Application: 2025 VS 2032 Figure 10. Hospital Image Figure 11. Rehabilitation Institutions Image Figure 12. Others Image Figure 13. Global Medications for Alcohol Use Disorder (AUD) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Medications for Alcohol Use Disorder (AUD) Market Size (2021-2032) & (US$ Million) Figure 15. Global Medications for Alcohol Use Disorder (AUD) Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Medications for Alcohol Use Disorder (AUD) Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Medications for Alcohol Use Disorder (AUD) Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Medications for Alcohol Use Disorder (AUD) Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Medications for Alcohol Use Disorder (AUD) Revenue Market Share by Type (2021-2032) Figure 22. Global Medications for Alcohol Use Disorder (AUD) Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Medications for Alcohol Use Disorder (AUD) Revenue Market Share by Application (2021-2032) Figure 24. North America Medications for Alcohol Use Disorder (AUD) Market Size (2021-2032) & (US$ Million) Figure 25. North America Medications for Alcohol Use Disorder (AUD) Market Share by Type (2021-2032) Figure 26. North America Medications for Alcohol Use Disorder (AUD) Market Share by Application (2021-2032) Figure 27. North America Medications for Alcohol Use Disorder (AUD) Market Share by Country (2021-2032) Figure 28. United States Medications for Alcohol Use Disorder (AUD) Market Size (2021-2032) & (US$ Million) Figure 29. Canada Medications for Alcohol Use Disorder (AUD) Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Medications for Alcohol Use Disorder (AUD) Market Size (2021-2032) & (US$ Million) Figure 31. Europe Medications for Alcohol Use Disorder (AUD) Market Size (2021-2032) & (US$ Million) Figure 32. Europe Medications for Alcohol Use Disorder (AUD) Market Share by Type (2021-2032) Figure 33. Europe Medications for Alcohol Use Disorder (AUD) Market Share by Application (2021-2032) Figure 34. Europe Medications for Alcohol Use Disorder (AUD) Market Share by Country (2021-2032) Figure 35. Germany Medications for Alcohol Use Disorder (AUD) Market Size (2021-2032) & (US$ Million) Figure 36. France Medications for Alcohol Use Disorder (AUD) Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Medications for Alcohol Use Disorder (AUD) Market Size (2021-2032) & (US$ Million) Figure 38. Italy Medications for Alcohol Use Disorder (AUD) Market Size (2021-2032) & (US$ Million) Figure 39. Russia Medications for Alcohol Use Disorder (AUD) Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Medications for Alcohol Use Disorder (AUD) Market Size (2021-2032) & (US$ Million) Figure 41. China Medications for Alcohol Use Disorder (AUD) Market Size (2021-2032) & (US$ Million) Figure 42. China Medications for Alcohol Use Disorder (AUD) Market Share by Type (2021-2032) Figure 43. China Medications for Alcohol Use Disorder (AUD) Market Share by Application (2021-2032) Figure 44. Asia Medications for Alcohol Use Disorder (AUD) Market Size (2021-2032) & (US$ Million) Figure 45. Asia Medications for Alcohol Use Disorder (AUD) Market Share by Type (2021-2032) Figure 46. Asia Medications for Alcohol Use Disorder (AUD) Market Share by Application (2021-2032) Figure 47. Asia Medications for Alcohol Use Disorder (AUD) Market Share by Country (2021-2032) Figure 48. Japan Medications for Alcohol Use Disorder (AUD) Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Medications for Alcohol Use Disorder (AUD) Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Medications for Alcohol Use Disorder (AUD) Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Medications for Alcohol Use Disorder (AUD) Market Size (2021-2032) & (US$ Million) Figure 52. India Medications for Alcohol Use Disorder (AUD) Market Size (2021-2032) & (US$ Million) Figure 53. Australia Medications for Alcohol Use Disorder (AUD) Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Share by Country (2021-2032) Figure 58. Brazil Medications for Alcohol Use Disorder (AUD) Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Medications for Alcohol Use Disorder (AUD) Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Medications for Alcohol Use Disorder (AUD) Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Medications for Alcohol Use Disorder (AUD) Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Medications for Alcohol Use Disorder (AUD) Market Size (2021-2032) & (US$ Million) Figure 63. UAE Medications for Alcohol Use Disorder (AUD) Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Medications for Alcohol Use Disorder (AUD) Market Size (2021-2032) & (US$ Million) Figure 65. Chile Medications for Alcohol Use Disorder (AUD) Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Acamprosate
  • Naltrexone
  • Disulfiram
  • Other
Applications
  • Hospital
  • Rehabilitation Institutions
  • Others
Companies covered
  • Teva
  • Sun Pharmaceutical Industries
  • Merck KGaA
  • Mylan
  • Beijing Wellso Pharmaceutical Co
  • Zydus Pharmaceuticals
  • Taj Pharmaceuticals
  • TAGI Pharma Inc.
  • Rusan Pharma Ltd
  • Lundbeck
  • Glenmark Pharmaceuticals
  • Alvogen
  • Alkermes

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Acamprosate
  5. 1.2.3 Naltrexone
  6. 1.2.4 Disulfiram
  7. 1.2.5 Other
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Rehabilitation Institutions
  12. 1.3.4 Others
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Medications for Alcohol Use Disorder (AUD) Growth Trends by Region
  15. 1.5.1 Global Medications for Alcohol Use Disorder (AUD) Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Medications for Alcohol Use Disorder (AUD) Market Size by Region (2021-2026)
  17. 1.5.3 Medications for Alcohol Use Disorder (AUD) Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Medications for Alcohol Use Disorder (AUD) Market Dynamics
  1. 2.1 Medications for Alcohol Use Disorder (AUD) Industry Trends
  2. 2.2 Medications for Alcohol Use Disorder (AUD) Industry Drivers
  3. 2.3 Medications for Alcohol Use Disorder (AUD) Industry Opportunities and Challenges
  4. 2.4 Medications for Alcohol Use Disorder (AUD) Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Medications for Alcohol Use Disorder (AUD) Revenue by Company (2021-2026)
  2. 3.2 Global Medications for Alcohol Use Disorder (AUD) Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Medications for Alcohol Use Disorder (AUD) Key Company Head office and Area Served
  4. 3.4 Global Medications for Alcohol Use Disorder (AUD) Company, Product Type & Application
  5. 3.5 Global Medications for Alcohol Use Disorder (AUD) Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Medications for Alcohol Use Disorder (AUD) Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Medications for Alcohol Use Disorder (AUD) Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Medications for Alcohol Use Disorder (AUD) Tier 1, Tier 2, and Tier 3
4 Medications for Alcohol Use Disorder (AUD) Market by Type
  1. 4.1 Global Medications for Alcohol Use Disorder (AUD) Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Medications for Alcohol Use Disorder (AUD) Market Size by Type (2021-2032)
  3. 4.3 Global Medications for Alcohol Use Disorder (AUD) Market Size Share by Type (2021-2032)
5 Medications for Alcohol Use Disorder (AUD) Market by Application
  1. 5.1 Global Medications for Alcohol Use Disorder (AUD) Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Medications for Alcohol Use Disorder (AUD) Market Size by Application (2021-2032)
  3. 5.3 Global Medications for Alcohol Use Disorder (AUD) Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Medications for Alcohol Use Disorder (AUD) Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Teva Medications for Alcohol Use Disorder (AUD) Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 Sun Pharmaceutical Industries
  8. 6.2.1 Sun Pharmaceutical Industries Company Information
  9. 6.2.2 Sun Pharmaceutical Industries Business Overview
  10. 6.2.3 Sun Pharmaceutical Industries Medications for Alcohol Use Disorder (AUD) Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Sun Pharmaceutical Industries Medications for Alcohol Use Disorder (AUD) Product Portfolio
  12. 6.2.5 Sun Pharmaceutical Industries Recent Developments
  13. 6.3 Merck KGaA
  14. 6.3.1 Merck KGaA Company Information
  15. 6.3.2 Merck KGaA Business Overview
  16. 6.3.3 Merck KGaA Medications for Alcohol Use Disorder (AUD) Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Merck KGaA Medications for Alcohol Use Disorder (AUD) Product Portfolio
  18. 6.3.5 Merck KGaA Recent Developments
  19. 6.4 Mylan
  20. 6.4.1 Mylan Company Information
  21. 6.4.2 Mylan Business Overview
  22. 6.4.3 Mylan Medications for Alcohol Use Disorder (AUD) Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Mylan Medications for Alcohol Use Disorder (AUD) Product Portfolio
  24. 6.4.5 Mylan Recent Developments
  25. 6.5 Beijing Wellso Pharmaceutical Co
  26. 6.5.1 Beijing Wellso Pharmaceutical Co Company Information
  27. 6.5.2 Beijing Wellso Pharmaceutical Co Business Overview
  28. 6.5.3 Beijing Wellso Pharmaceutical Co Medications for Alcohol Use Disorder (AUD) Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Beijing Wellso Pharmaceutical Co Medications for Alcohol Use Disorder (AUD) Product Portfolio
  30. 6.5.5 Beijing Wellso Pharmaceutical Co Recent Developments
  31. 6.6 Zydus Pharmaceuticals
  32. 6.6.1 Zydus Pharmaceuticals Company Information
  33. 6.6.2 Zydus Pharmaceuticals Business Overview
  34. 6.6.3 Zydus Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Zydus Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Product Portfolio
  36. 6.6.5 Zydus Pharmaceuticals Recent Developments
  37. 6.7 Taj Pharmaceuticals
  38. 6.7.1 Taj Pharmaceuticals Company Information
  39. 6.7.2 Taj Pharmaceuticals Business Overview
  40. 6.7.3 Taj Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Taj Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Product Portfolio
  42. 6.7.5 Taj Pharmaceuticals Recent Developments
  43. 6.8 TAGI Pharma Inc.
  44. 6.8.1 TAGI Pharma Inc. Company Information
  45. 6.8.2 TAGI Pharma Inc. Business Overview
  46. 6.8.3 TAGI Pharma Inc. Medications for Alcohol Use Disorder (AUD) Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 TAGI Pharma Inc. Medications for Alcohol Use Disorder (AUD) Product Portfolio
  48. 6.8.5 TAGI Pharma Inc. Recent Developments
  49. 6.9 Rusan Pharma Ltd
  50. 6.9.1 Rusan Pharma Ltd Company Information
  51. 6.9.2 Rusan Pharma Ltd Business Overview
  52. 6.9.3 Rusan Pharma Ltd Medications for Alcohol Use Disorder (AUD) Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Rusan Pharma Ltd Medications for Alcohol Use Disorder (AUD) Product Portfolio
  54. 6.9.5 Rusan Pharma Ltd Recent Developments
  55. 6.10 Lundbeck
  56. 6.10.1 Lundbeck Company Information
  57. 6.10.2 Lundbeck Business Overview
  58. 6.10.3 Lundbeck Medications for Alcohol Use Disorder (AUD) Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Lundbeck Medications for Alcohol Use Disorder (AUD) Product Portfolio
  60. 6.10.5 Lundbeck Recent Developments
  61. 6.11 Glenmark Pharmaceuticals
  62. 6.11.1 Glenmark Pharmaceuticals Company Information
  63. 6.11.2 Glenmark Pharmaceuticals Business Overview
  64. 6.11.3 Glenmark Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Glenmark Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Product Portfolio
  66. 6.11.5 Glenmark Pharmaceuticals Recent Developments
  67. 6.12 Alvogen
  68. 6.12.1 Alvogen Company Information
  69. 6.12.2 Alvogen Business Overview
  70. 6.12.3 Alvogen Medications for Alcohol Use Disorder (AUD) Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Alvogen Medications for Alcohol Use Disorder (AUD) Product Portfolio
  72. 6.12.5 Alvogen Recent Developments
  73. 6.13 Alkermes
  74. 6.13.1 Alkermes Company Information
  75. 6.13.2 Alkermes Business Overview
  76. 6.13.3 Alkermes Medications for Alcohol Use Disorder (AUD) Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Alkermes Medications for Alcohol Use Disorder (AUD) Product Portfolio
  78. 6.13.5 Alkermes Recent Developments
7 North America
  1. 7.1 North America Medications for Alcohol Use Disorder (AUD) Market Size (2021-2032)
  2. 7.2 North America Medications for Alcohol Use Disorder (AUD) Market Size by Type
  3. 7.2.1 North America Medications for Alcohol Use Disorder (AUD) Market Size by Type (2021-2026)
  4. 7.2.2 North America Medications for Alcohol Use Disorder (AUD) Market Size by Type (2027-2032)
  5. 7.2.3 North America Medications for Alcohol Use Disorder (AUD) Market Share by Type (2021-2032)
  6. 7.3 North America Medications for Alcohol Use Disorder (AUD) Market Size by Application
  7. 7.3.1 North America Medications for Alcohol Use Disorder (AUD) Market Size by Application (2021-2026)
  8. 7.3.2 North America Medications for Alcohol Use Disorder (AUD) Market Size by Application (2027-2032)
  9. 7.3.3 North America Medications for Alcohol Use Disorder (AUD) Market Share by Application (2021-2032)
  10. 7.4 North America Medications for Alcohol Use Disorder (AUD) Market Size by Country
  11. 7.4.1 North America Medications for Alcohol Use Disorder (AUD) Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Medications for Alcohol Use Disorder (AUD) Market Size by Country (2021-2026)
  13. 7.4.3 North America Medications for Alcohol Use Disorder (AUD) Market Size by Country (2027-2032)
  14. 7.4.4 North America Medications for Alcohol Use Disorder (AUD) Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Medications for Alcohol Use Disorder (AUD) Market Size (2021-2032)
  2. 8.2 Europe Medications for Alcohol Use Disorder (AUD) Market Size by Type
  3. 8.2.1 Europe Medications for Alcohol Use Disorder (AUD) Market Size by Type (2021-2026)
  4. 8.2.2 Europe Medications for Alcohol Use Disorder (AUD) Market Size by Type (2027-2032)
  5. 8.2.3 Europe Medications for Alcohol Use Disorder (AUD) Market Share by Type (2021-2032)
  6. 8.3 Europe Medications for Alcohol Use Disorder (AUD) Market Size by Application
  7. 8.3.1 Europe Medications for Alcohol Use Disorder (AUD) Market Size by Application (2021-2026)
  8. 8.3.2 Europe Medications for Alcohol Use Disorder (AUD) Market Size by Application (2027-2032)
  9. 8.3.3 Europe Medications for Alcohol Use Disorder (AUD) Market Share by Application (2021-2032)
  10. 8.4 Europe Medications for Alcohol Use Disorder (AUD) Market Size by Country
  11. 8.4.1 Europe Medications for Alcohol Use Disorder (AUD) Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Medications for Alcohol Use Disorder (AUD) Market Size by Country (2021-2026)
  13. 8.4.3 Europe Medications for Alcohol Use Disorder (AUD) Market Size by Country (2027-2032)
  14. 8.4.4 Europe Medications for Alcohol Use Disorder (AUD) Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Medications for Alcohol Use Disorder (AUD) Market Size (2021-2032)
  2. 9.2 China Medications for Alcohol Use Disorder (AUD) Market Size by Type
  3. 9.2.1 China Medications for Alcohol Use Disorder (AUD) Market Size by Type (2021-2026)
  4. 9.2.2 China Medications for Alcohol Use Disorder (AUD) Market Size by Type (2027-2032)
  5. 9.2.3 China Medications for Alcohol Use Disorder (AUD) Market Share by Type (2021-2032)
  6. 9.3 China Medications for Alcohol Use Disorder (AUD) Market Size by Application
  7. 9.3.1 China Medications for Alcohol Use Disorder (AUD) Market Size by Application (2021-2026)
  8. 9.3.2 China Medications for Alcohol Use Disorder (AUD) Market Size by Application (2027-2032)
  9. 9.3.3 China Medications for Alcohol Use Disorder (AUD) Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Medications for Alcohol Use Disorder (AUD) Market Size (2021-2032)
  2. 10.2 Asia Medications for Alcohol Use Disorder (AUD) Market Size by Type
  3. 10.2.1 Asia Medications for Alcohol Use Disorder (AUD) Market Size by Type (2021-2026)
  4. 10.2.2 Asia Medications for Alcohol Use Disorder (AUD) Market Size by Type (2027-2032)
  5. 10.2.3 Asia Medications for Alcohol Use Disorder (AUD) Market Share by Type (2021-2032)
  6. 10.3 Asia Medications for Alcohol Use Disorder (AUD) Market Size by Application
  7. 10.3.1 Asia Medications for Alcohol Use Disorder (AUD) Market Size by Application (2021-2026)
  8. 10.3.2 Asia Medications for Alcohol Use Disorder (AUD) Market Size by Application (2027-2032)
  9. 10.3.3 Asia Medications for Alcohol Use Disorder (AUD) Market Share by Application (2021-2032)
  10. 10.4 Asia Medications for Alcohol Use Disorder (AUD) Market Size by Country
  11. 10.4.1 Asia Medications for Alcohol Use Disorder (AUD) Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Medications for Alcohol Use Disorder (AUD) Market Size by Country (2021-2026)
  13. 10.4.3 Asia Medications for Alcohol Use Disorder (AUD) Market Size by Country (2027-2032)
  14. 10.4.4 Asia Medications for Alcohol Use Disorder (AUD) Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst